C-reactive protein modulates lipid mediators in a pro-inflammatory direction

Area of Science:

• Biochemistry
• Immunology
• Cardiovascular Research

Background:

• C-reactive protein (CRP) is a known risk factor for atherosclerosis.
• While inflammation may confound this association, CRP itself is suspected of having pro-atherosclerotic and pro-inflammatory roles.

Purpose of the Study:

• To investigate the mechanisms by which CRP modulates bioactive lipid mediators.
• To understand CRP's role in lipid metabolism and inflammation relevant to atherosclerosis.

Main Methods:

• Overexpression of human CRP in mice and HepG2 cells.
• Analysis of cytokine levels (IL-6, TNF-a) in plasma and cell culture.
• Comprehensive lipidomics analysis of plasma samples.
• Investigation of CRP's binding interactions with specific lipid mediators.

Main Results:

• CRP overexpression elevated plasma IL-6 and TNF-a levels in mice.
• CRP increased plasma levels of lysophospholipids and sphingosine 1-phosphate.
• CRP promoted pro-inflammatory lipid mediators (e.g., PGE2, LTA4 metabolites) while reducing anti-inflammatory ones (EPA, DHA derivatives).
• CRP was found to bind directly to mediators like sphingosine 1-phosphate, PGE2, and PGF2a.

Conclusions:

• CRP modulates lysophospholipids and eicosanoids.
• These modulations appear to be in pro-atherosclerotic and pro-inflammatory directions.
• CRP may directly influence lipid mediator pathways contributing to atherosclerosis.